Table of Content

1 Angiogenesis Modulators Market Overview
1.1 Angiogenesis Modulators Product Scope
1.2 Angiogenesis Modulators Segment by Type
1.2.1 Global Angiogenesis Modulators Sales by Type (2016 & 2021 & 2027)
1.2.2 Angiogenesis Inhibitors
1.2.3 Angiogenesis Stimulators
1.2.4 Angiogenin
1.2.5 Others
1.3 Angiogenesis Modulators Segment by Application
1.3.1 Global Angiogenesis Modulators Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Lung Cancer
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Angiogenesis Modulators Market Estimates and Forecasts (2016-2027)
1.4.1 Global Angiogenesis Modulators Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Angiogenesis Modulators Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Angiogenesis Modulators Price Trends (2016-2027)

2 Angiogenesis Modulators Estimates and Forecasts by Region
2.1 Global Angiogenesis Modulators Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Angiogenesis Modulators Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Angiogenesis Modulators Sales Market Share by Region (2016-2021)
2.2.2 Global Angiogenesis Modulators Revenue Market Share by Region (2016-2021)
2.3 Global Angiogenesis Modulators Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Angiogenesis Modulators Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Angiogenesis Modulators Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Angiogenesis Modulators Estimates and Projections (2016-2027)
2.4.2 Europe Angiogenesis Modulators Estimates and Projections (2016-2027)
2.4.3 China Angiogenesis Modulators Estimates and Projections (2016-2027)
2.4.4 Japan Angiogenesis Modulators Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Angiogenesis Modulators Estimates and Projections (2016-2027)
2.4.6 India Angiogenesis Modulators Estimates and Projections (2016-2027)

3 Global Angiogenesis Modulators Competition Landscape by Players
3.1 Global Top Angiogenesis Modulators Players by Sales (2016-2021)
3.2 Global Top Angiogenesis Modulators Players by Revenue (2016-2021)
3.3 Global Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiogenesis Modulators as of 2020)
3.4 Global Angiogenesis Modulators Average Price by Company (2016-2021)
3.5 Manufacturers Angiogenesis Modulators Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Angiogenesis Modulators Market Size by Type
4.1 Global Angiogenesis Modulators Historic Market Review by Type (2016-2021)
4.1.1 Global Angiogenesis Modulators Sales Market Share by Type (2016-2021)
4.1.2 Global Angiogenesis Modulators Revenue Market Share by Type (2016-2021)
4.1.3 Global Angiogenesis Modulators Price by Type (2016-2021)
4.2 Global Angiogenesis Modulators Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Angiogenesis Modulators Sales Forecast by Type (2022-2027)
4.2.2 Global Angiogenesis Modulators Revenue Forecast by Type (2022-2027)
4.2.3 Global Angiogenesis Modulators Price Forecast by Type (2022-2027)

5 Global Angiogenesis Modulators Market Size by Application
5.1 Global Angiogenesis Modulators Historic Market Review by Application (2016-2021)
5.1.1 Global Angiogenesis Modulators Sales Market Share by Application (2016-2021)
5.1.2 Global Angiogenesis Modulators Revenue Market Share by Application (2016-2021)
5.1.3 Global Angiogenesis Modulators Price by Application (2016-2021)
5.2 Global Angiogenesis Modulators Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Angiogenesis Modulators Sales Forecast by Application (2022-2027)
5.2.2 Global Angiogenesis Modulators Revenue Forecast by Application (2022-2027)
5.2.3 Global Angiogenesis Modulators Price Forecast by Application (2022-2027)

6 North America Angiogenesis Modulators Market Facts & Figures
6.1 North America Angiogenesis Modulators Sales by Company
6.1.1 North America Angiogenesis Modulators Sales by Company (2016-2021)
6.1.2 North America Angiogenesis Modulators Revenue by Company (2016-2021)
6.2 North America Angiogenesis Modulators Sales Breakdown by Type
6.2.1 North America Angiogenesis Modulators Sales Breakdown by Type (2016-2021)
6.2.2 North America Angiogenesis Modulators Sales Breakdown by Type (2022-2027)
6.3 North America Angiogenesis Modulators Sales Breakdown by Application
6.3.1 North America Angiogenesis Modulators Sales Breakdown by Application (2016-2021)
6.3.2 North America Angiogenesis Modulators Sales Breakdown by Application (2022-2027)

7 Europe Angiogenesis Modulators Market Facts & Figures
7.1 Europe Angiogenesis Modulators Sales by Company
7.1.1 Europe Angiogenesis Modulators Sales by Company (2016-2021)
7.1.2 Europe Angiogenesis Modulators Revenue by Company (2016-2021)
7.2 Europe Angiogenesis Modulators Sales Breakdown by Type
7.2.1 Europe Angiogenesis Modulators Sales Breakdown by Type (2016-2021)
7.2.2 Europe Angiogenesis Modulators Sales Breakdown by Type (2022-2027)
7.3 Europe Angiogenesis Modulators Sales Breakdown by Application
7.3.1 Europe 128 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 128 Sales Breakdown by Application (2022-2027)

8 China Angiogenesis Modulators Market Facts & Figures
8.1 China Angiogenesis Modulators Sales by Company
8.1.1 China Angiogenesis Modulators Sales by Company (2016-2021)
8.1.2 China Angiogenesis Modulators Revenue by Company (2016-2021)
8.2 China Angiogenesis Modulators Sales Breakdown by Type
8.2.1 China Angiogenesis Modulators Sales Breakdown by Type (2016-2021)
8.2.2 China Angiogenesis Modulators Sales Breakdown by Type (2022-2027)
8.3 China Angiogenesis Modulators Sales Breakdown by Application
8.3.1 China 152 Sales Breakdown by Application (2016-2021)
8.3.2 China 152 Sales Breakdown by Application (2022-2027)

9 Japan Angiogenesis Modulators Market Facts & Figures
9.1 Japan Angiogenesis Modulators Sales by Company
9.1.1 Japan Angiogenesis Modulators Sales by Company (2016-2021)
9.1.2 Japan Angiogenesis Modulators Revenue by Company (2016-2021)
9.2 Japan Angiogenesis Modulators Sales Breakdown by Type
9.2.1 Japan Angiogenesis Modulators Sales Breakdown by Type (2016-2021)
9.2.2 Japan Angiogenesis Modulators Sales Breakdown by Type (2022-2027)
9.3 Japan Angiogenesis Modulators Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Angiogenesis Modulators Market Facts & Figures
10.1 Southeast Asia Angiogenesis Modulators Sales by Company
10.1.1 Southeast Asia Angiogenesis Modulators Sales by Company (2016-2021)
10.1.2 Southeast Asia Angiogenesis Modulators Revenue by Company (2016-2021)
10.2 Southeast Asia Angiogenesis Modulators Sales Breakdown by Type
10.2.1 Southeast Asia Angiogenesis Modulators Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Angiogenesis Modulators Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Angiogenesis Modulators Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Angiogenesis Modulators Market Facts & Figures
11.1 India Angiogenesis Modulators Sales by Company
11.1.1 India Angiogenesis Modulators Sales by Company (2016-2021)
11.1.2 India Angiogenesis Modulators Revenue by Company (2016-2021)
11.2 India Angiogenesis Modulators Sales Breakdown by Type
11.2.1 India Angiogenesis Modulators Sales Breakdown by Type (2016-2021)
11.2.2 India Angiogenesis Modulators Sales Breakdown by Type (2022-2027)
11.3 India Angiogenesis Modulators Sales Breakdown by Application
11.3.1 India Angiogenesis Modulators Sales Breakdown by Application (2016-2021)
11.3.2 India Angiogenesis Modulators Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Angiogenesis Modulators Business
12.1 Celgene Corporation (USA)
12.1.1 Celgene Corporation (USA) Corporation Information
12.1.2 Celgene Corporation (USA) Business Overview
12.1.3 Celgene Corporation (USA) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Celgene Corporation (USA) Angiogenesis Modulators Products Offered
12.1.5 Celgene Corporation (USA) Recent Development
12.2 Eisai (Japan)
12.2.1 Eisai (Japan) Corporation Information
12.2.2 Eisai (Japan) Business Overview
12.2.3 Eisai (Japan) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eisai (Japan) Angiogenesis Modulators Products Offered
12.2.5 Eisai (Japan) Recent Development
12.3 Amgen, Inc. (USA)
12.3.1 Amgen, Inc. (USA) Corporation Information
12.3.2 Amgen, Inc. (USA) Business Overview
12.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Amgen, Inc. (USA) Angiogenesis Modulators Products Offered
12.3.5 Amgen, Inc. (USA) Recent Development
12.4 Genentech, Inc. (USA)
12.4.1 Genentech, Inc. (USA) Corporation Information
12.4.2 Genentech, Inc. (USA) Business Overview
12.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Genentech, Inc. (USA) Angiogenesis Modulators Products Offered
12.4.5 Genentech, Inc. (USA) Recent Development
12.5 GlaxoSmithKline plc (UK)
12.5.1 GlaxoSmithKline plc (UK) Corporation Information
12.5.2 GlaxoSmithKline plc (UK) Business Overview
12.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline plc (UK) Angiogenesis Modulators Products Offered
12.5.5 GlaxoSmithKline plc (UK) Recent Development
12.6 Bayer Pharma AG (Germany)
12.6.1 Bayer Pharma AG (Germany) Corporation Information
12.6.2 Bayer Pharma AG (Germany) Business Overview
12.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bayer Pharma AG (Germany) Angiogenesis Modulators Products Offered
12.6.5 Bayer Pharma AG (Germany) Recent Development
12.7 Bionomics Ltd. (Australia)
12.7.1 Bionomics Ltd. (Australia) Corporation Information
12.7.2 Bionomics Ltd. (Australia) Business Overview
12.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bionomics Ltd. (Australia) Angiogenesis Modulators Products Offered
12.7.5 Bionomics Ltd. (Australia) Recent Development
12.8 CASI Pharmaceuticals, Inc. (USA)
12.8.1 CASI Pharmaceuticals, Inc. (USA) Corporation Information
12.8.2 CASI Pharmaceuticals, Inc. (USA) Business Overview
12.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Products Offered
12.8.5 CASI Pharmaceuticals, Inc. (USA) Recent Development
12.9 AstraZeneca plc (UK)
12.9.1 AstraZeneca plc (UK) Corporation Information
12.9.2 AstraZeneca plc (UK) Business Overview
12.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.9.4 AstraZeneca plc (UK) Angiogenesis Modulators Products Offered
12.9.5 AstraZeneca plc (UK) Recent Development
12.10 Eli Lilly and Company (USA)
12.10.1 Eli Lilly and Company (USA) Corporation Information
12.10.2 Eli Lilly and Company (USA) Business Overview
12.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Eli Lilly and Company (USA) Angiogenesis Modulators Products Offered
12.10.5 Eli Lilly and Company (USA) Recent Development
12.11 F.Hoffmann-La Roche AG (Switzerland)
12.11.1 F.Hoffmann-La Roche AG (Switzerland) Corporation Information
12.11.2 F.Hoffmann-La Roche AG (Switzerland) Business Overview
12.11.3 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales, Revenue and Gross Margin (2016-2021)
12.11.4 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Products Offered
12.11.5 F.Hoffmann-La Roche AG (Switzerland) Recent Development

13 Angiogenesis Modulators Manufacturing Cost Analysis
13.1 Angiogenesis Modulators Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Angiogenesis Modulators
13.4 Angiogenesis Modulators Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Angiogenesis Modulators Distributors List
14.3 Angiogenesis Modulators Customers

15 Market Dynamics
15.1 Angiogenesis Modulators Market Trends
15.2 Angiogenesis Modulators Drivers
15.3 Angiogenesis Modulators Market Challenges
15.4 Angiogenesis Modulators Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Angiogenesis Modulators Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Angiogenesis Modulators Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Angiogenesis Modulators Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Angiogenesis Modulators Sales (K MT) by Region (2016-2021)
Table 5. Global Angiogenesis Modulators Sales Market Share by Region (2016-2021)
Table 6. Global Angiogenesis Modulators Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Angiogenesis Modulators Revenue Share by Region (2016-2021)
Table 8. Global Angiogenesis Modulators Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Angiogenesis Modulators Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Angiogenesis Modulators Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Angiogenesis Modulators Revenue Share Forecast by Region (2022-2027)
Table 12. Global Angiogenesis Modulators Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Angiogenesis Modulators Sales Share by Company (2016-2021)
Table 14. Global Angiogenesis Modulators Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Angiogenesis Modulators Revenue Share by Company (2016-2021)
Table 16. Global Angiogenesis Modulators by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiogenesis Modulators as of 2020)
Table 17. Global Angiogenesis Modulators Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Angiogenesis Modulators Manufacturing Sites and Area Served
Table 19. Manufacturers Angiogenesis Modulators Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Angiogenesis Modulators Sales (K MT) by Type (2016-2021)
Table 22. Global Angiogenesis Modulators Sales Share by Type (2016-2021)
Table 23. Global Angiogenesis Modulators Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Angiogenesis Modulators Price (USD/MT) by Type (2016-2021)
Table 25. Global Angiogenesis Modulators Sales Share by Type (2022-2027)
Table 26. Global Angiogenesis Modulators Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Angiogenesis Modulators Revenue Share by Type (2022-2027)
Table 28. Global Angiogenesis Modulators Price (USD/MT) by Type (2022-2027)
Table 29. Global Angiogenesis Modulators Sales (K MT) by Application (2016-2021)
Table 30. Global Angiogenesis Modulators Sales Share by Application (2016-2021)
Table 31. Global Angiogenesis Modulators Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Angiogenesis Modulators Price (USD/MT) by Application (2016-2021)
Table 33. Global Angiogenesis Modulators Sales (K MT) by Application (2022-2027)
Table 34. Global Angiogenesis Modulators Sales Share by Application (2022-2027)
Table 35. Global Angiogenesis Modulators Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Angiogenesis Modulators Revenue Share by Application (2022-2027)
Table 37. Global Angiogenesis Modulators Price (USD/MT) by Application (2022-2027)
Table 38. North America Angiogenesis Modulators Sales (K MT) by Company (2016-2021)
Table 39. North America Angiogenesis Modulators Sales Market Share by Company (2016-2021)
Table 40. North America Angiogenesis Modulators Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Angiogenesis Modulators Revenue Market Share by Company (2016-2021)
Table 42. North America Angiogenesis Modulators Sales by Type (2016-2021) & (K MT)
Table 43. North America Angiogenesis Modulators Sales Market Share by Type (2016-2021)
Table 44. North America Angiogenesis Modulators Sales by Type (2022-2027) & (K MT)
Table 45. North America Angiogenesis Modulators Sales Market Share by Type (2022-2027)
Table 46. North America Angiogenesis Modulators Sales by Application (2016-2021) & (K MT)
Table 47. North America Angiogenesis Modulators Sales Market Share by Application (2016-2021)
Table 48. North America Angiogenesis Modulators Sales by Application (2022-2027) & (K MT)
Table 49. North America Angiogenesis Modulators Sales Market Share by Application (2022-2027)
Table 50. Europe Angiogenesis Modulators Sales (K MT) by Company (2016-2021)
Table 51. Europe Angiogenesis Modulators Sales Market Share by Company (2016-2021)
Table 52. Europe Angiogenesis Modulators Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Angiogenesis Modulators Revenue Market Share by Company (2016-2021)
Table 54. Europe Angiogenesis Modulators Sales by Type (2016-2021) & (K MT)
Table 55. Europe Angiogenesis Modulators Sales Market Share by Type (2016-2021)
Table 56. Europe Angiogenesis Modulators Sales by Type (2022-2027) & (K MT)
Table 57. Europe Angiogenesis Modulators Sales Market Share by Type (2022-2027)
Table 58. Europe Angiogenesis Modulators Sales by Application (2016-2021) & (K MT)
Table 59. Europe Angiogenesis Modulators Sales Market Share by Application (2016-2021)
Table 60. Europe Angiogenesis Modulators Sales by Application (2022-2027) & (K MT)
Table 61. Europe Angiogenesis Modulators Sales Market Share by Application (2022-2027)
Table 62. China Angiogenesis Modulators Sales (K MT) by Company (2016-2021)
Table 63. China Angiogenesis Modulators Sales Market Share by Company (2016-2021)
Table 64. China Angiogenesis Modulators Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Angiogenesis Modulators Revenue Market Share by Company (2016-2021)
Table 66. China Angiogenesis Modulators Sales by Type (2016-2021) & (K MT)
Table 67. China Angiogenesis Modulators Sales Market Share by Type (2016-2021)
Table 68. China Angiogenesis Modulators Sales by Type (2022-2027) & (K MT)
Table 69. China Angiogenesis Modulators Sales Market Share by Type (2022-2027)
Table 70. China Angiogenesis Modulators Sales by Application (2016-2021) & (K MT)
Table 71. China Angiogenesis Modulators Sales Market Share by Application (2016-2021)
Table 72. China Angiogenesis Modulators Sales by Application (2022-2027) & (K MT)
Table 73. China Angiogenesis Modulators Sales Market Share by Application (2022-2027)
Table 74. Japan Angiogenesis Modulators Sales (K MT) by Company (2016-2021)
Table 75. Japan Angiogenesis Modulators Sales Market Share by Company (2016-2021)
Table 76. Japan Angiogenesis Modulators Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Angiogenesis Modulators Revenue Market Share by Company (2016-2021)
Table 78. Japan Angiogenesis Modulators Sales by Type (2016-2021) & (K MT)
Table 79. Japan Angiogenesis Modulators Sales Market Share by Type (2016-2021)
Table 80. Japan Angiogenesis Modulators Sales by Type (2022-2027) & (K MT)
Table 81. Japan Angiogenesis Modulators Sales Market Share by Type (2022-2027)
Table 82. Japan Angiogenesis Modulators Sales by Application (2016-2021) & (K MT)
Table 83. Japan Angiogenesis Modulators Sales Market Share by Application (2016-2021)
Table 84. Japan Angiogenesis Modulators Sales by Application (2022-2027) & (K MT)
Table 85. Japan Angiogenesis Modulators Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Angiogenesis Modulators Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Angiogenesis Modulators Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Angiogenesis Modulators Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Angiogenesis Modulators Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Angiogenesis Modulators Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Angiogenesis Modulators Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Angiogenesis Modulators Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Angiogenesis Modulators Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Angiogenesis Modulators Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Angiogenesis Modulators Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Angiogenesis Modulators Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Angiogenesis Modulators Sales Market Share by Application (2022-2027)
Table 98. India Angiogenesis Modulators Sales (K MT) by Company (2016-2021)
Table 99. India Angiogenesis Modulators Sales Market Share by Company (2016-2021)
Table 100. India Angiogenesis Modulators Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Angiogenesis Modulators Revenue Market Share by Company (2016-2021)
Table 102. India Angiogenesis Modulators Sales by Type (2016-2021) & (K MT)
Table 103. India Angiogenesis Modulators Sales Market Share by Type (2016-2021)
Table 104. India Angiogenesis Modulators Sales by Type (2022-2027) & (K MT)
Table 105. India Angiogenesis Modulators Sales Market Share by Type (2022-2027)
Table 106. India Angiogenesis Modulators Sales by Application (2016-2021) & (K MT)
Table 107. India Angiogenesis Modulators Sales Market Share by Application (2016-2021)
Table 108. India Angiogenesis Modulators Sales by Application (2022-2027) & (K MT)
Table 109. India Angiogenesis Modulators Sales Market Share by Application (2022-2027)
Table 110. Celgene Corporation (USA) Corporation Information
Table 111. Celgene Corporation (USA) Description and Business Overview
Table 112. Celgene Corporation (USA) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Celgene Corporation (USA) Angiogenesis Modulators Product
Table 114. Celgene Corporation (USA) Recent Development
Table 115. Eisai (Japan) Corporation Information
Table 116. Eisai (Japan) Description and Business Overview
Table 117. Eisai (Japan) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Eisai (Japan) Angiogenesis Modulators Product
Table 119. Eisai (Japan) Recent Development
Table 120. Amgen, Inc. (USA) Corporation Information
Table 121. Amgen, Inc. (USA) Description and Business Overview
Table 122. Amgen, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Amgen, Inc. (USA) Angiogenesis Modulators Product
Table 124. Amgen, Inc. (USA) Recent Development
Table 125. Genentech, Inc. (USA) Corporation Information
Table 126. Genentech, Inc. (USA) Description and Business Overview
Table 127. Genentech, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Genentech, Inc. (USA) Angiogenesis Modulators Product
Table 129. Genentech, Inc. (USA) Recent Development
Table 130. GlaxoSmithKline plc (UK) Corporation Information
Table 131. GlaxoSmithKline plc (UK) Description and Business Overview
Table 132. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. GlaxoSmithKline plc (UK) Angiogenesis Modulators Product
Table 134. GlaxoSmithKline plc (UK) Recent Development
Table 135. Bayer Pharma AG (Germany) Corporation Information
Table 136. Bayer Pharma AG (Germany) Description and Business Overview
Table 137. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Bayer Pharma AG (Germany) Angiogenesis Modulators Product
Table 139. Bayer Pharma AG (Germany) Recent Development
Table 140. Bionomics Ltd. (Australia) Corporation Information
Table 141. Bionomics Ltd. (Australia) Description and Business Overview
Table 142. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Bionomics Ltd. (Australia) Angiogenesis Modulators Product
Table 144. Bionomics Ltd. (Australia) Recent Development
Table 145. CASI Pharmaceuticals, Inc. (USA) Corporation Information
Table 146. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. CASI Pharmaceuticals, Inc. (USA) Description and Business Overview
Table 148. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product
Table 149. CASI Pharmaceuticals, Inc. (USA) Recent Development
Table 150. AstraZeneca plc (UK) Corporation Information
Table 151. AstraZeneca plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. AstraZeneca plc (UK) Description and Business Overview
Table 153. AstraZeneca plc (UK) Angiogenesis Modulators Product
Table 154. AstraZeneca plc (UK) Recent Development
Table 155. Eli Lilly and Company (USA) Corporation Information
Table 156. Eli Lilly and Company (USA) Description and Business Overview
Table 157. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Eli Lilly and Company (USA) Angiogenesis Modulators Product
Table 159. Eli Lilly and Company (USA) Recent Development
Table 160. F.Hoffmann-La Roche AG (Switzerland) Corporation Information
Table 161. F.Hoffmann-La Roche AG (Switzerland) Description and Business Overview
Table 162. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product
Table 164. F.Hoffmann-La Roche AG (Switzerland) Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Angiogenesis Modulators Distributors List
Table 168. Angiogenesis Modulators Customers List
Table 169. Angiogenesis Modulators Market Trends
Table 170. Angiogenesis Modulators Market Drivers
Table 171. Angiogenesis Modulators Market Challenges
Table 172. Angiogenesis Modulators Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiogenesis Modulators Product Picture
Figure 2. Global Angiogenesis Modulators Sales Market Share by Type in 2021 & 2027
Figure 3. Angiogenesis Inhibitors Product Picture
Figure 4. Angiogenesis Stimulators Product Picture
Figure 5. Angiogenin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Angiogenesis Modulators Sales Market Share by Application in 2021 & 2027
Figure 8. Breast Cancer Examples
Figure 9. Colorectal Cancer Examples
Figure 10. Lung Cancer Examples
Figure 11. Prostate Cancer Examples
Figure 12. Others Examples
Figure 13. Global Angiogenesis Modulators Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Angiogenesis Modulators Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Angiogenesis Modulators Sales (K MT) Growth Rate (2016-2027)
Figure 16. Global Angiogenesis Modulators Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 17. Global Angiogenesis Modulators Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Angiogenesis Modulators Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Angiogenesis Modulators Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Angiogenesis Modulators Sales (K MT) Growth Rate (2016-2027)
Figure 21. Europe Angiogenesis Modulators Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Angiogenesis Modulators Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Angiogenesis Modulators Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Angiogenesis Modulators Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Angiogenesis Modulators Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Angiogenesis Modulators Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Angiogenesis Modulators Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Angiogenesis Modulators Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Angiogenesis Modulators Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Angiogenesis Modulators Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Angiogenesis Modulators Players Market Share by Revenue in Angiogenesis Modulators: 2016 & 2020
Figure 32. Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global Angiogenesis Modulators Revenue Share by Type (2016-2021)
Figure 34. Global Angiogenesis Modulators Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Global Angiogenesis Modulators Revenue Share by Application (2016-2021)
Figure 36. Global Angiogenesis Modulators Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Angiogenesis Modulators Sales Market Share by Type in 2020
Figure 38. North America Angiogenesis Modulators Sales Market Share by Application in 2020
Figure 39. Europe Angiogenesis Modulators Sales Market Share by Type in 2020
Figure 40. Europe Angiogenesis Modulators Sales Market Share by Application in 2020
Figure 41. China Angiogenesis Modulators Sales Market Share by Type in 2020
Figure 42. China Angiogenesis Modulators Sales Market Share by Application in 2020
Figure 43. Japan Angiogenesis Modulators Sales Market Share by Type in 2020
Figure 44. Japan Angiogenesis Modulators Sales Market Share by Application in 2020
Figure 45. Southeast Asia Angiogenesis Modulators Sales Market Share by Type in 2020
Figure 46. Southeast Asia Angiogenesis Modulators Sales Market Share by Application in 2020
Figure 47. India Angiogenesis Modulators Sales Market Share by Type in 2020
Figure 48. India Angiogenesis Modulators Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Angiogenesis Modulators
Figure 51. Manufacturing Process Analysis of Angiogenesis Modulators
Figure 52. Angiogenesis Modulators Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed